Amdocs Limited DOX

57.71 (0.65) (1.11%) as of 25 Sep
Market cap
$6.2B
P/E
13.7×
Growth Flags show if company had growth for consecutive years

Insider Decisions

Total sells 0.03
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — — — — — — — 1 — — — —
Insider Ownership 0.00%

Capital & Financial Ratios

Market Cap 6,220.00
Revenue 4,653.03
Net Income 457.53
Free Cash Flow 638.84
Net Debt 845.89
Current Ratio 0.94
Debt/Equity 0.32
P/E ratio 13.67
P/S ratio 1.28
P/B ratio 1.79
Past 5Y EPS Growth 4.11%
This Y EPS Growth 6.09%
Next Y EPS Growth 8.06%
Next 5Y EPS Growth 9.55%
in millions of $

Dividends

Payout Ratio 0.36
Annual Dividend Rate 1.74
Annual Dividend Yield 1.98%
total individual payouts
2028 Powerpack
2027 Powerpack
2026 2.11
0.57
0.57
0.57
2025 1.83
0.53
0.53
0.53
0.53
2024 1.92
0.48
0.48
0.48
0.48
2023 1.74
0.44
0.44
0.44
0.44
2022 1.98
0.40
0.40
0.40
0.40
0.40
2021 1.44
0.36
0.36
0.36
0.36
2020 1.31
0.33
0.33
0.33
0.33
2019 1.14
0.29
0.29
0.29
0.29
2018 1.00
0.25
0.25
0.25
0.25
2017 0.88
0.22
0.22
0.22
0.22
2016 0.78
0.20
0.20
0.20
0.20
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 743 514 325 206
Receivables 944 1,028 936 1,010
Inventory — — — —
Other — — — —
1,912 1,771 1,592 1,593
2023 2024 2025 Q'26
Payables 293 306 371 344
ST’ Debt 40 — — 280
Other — — — —
1,353 1,471 1,359 1,702
in millions of $

Compound Annual Growth

10y 5y 3y
Sales 2.21% 1.69% (0.32%)
Cash Flow (0.31%) 2.62% (0.34%)
Earnings 2.30% 2.32% 0.76%
Book Value 0.19% (1.08%) (0.85%)

Revenue

Dec Mar Jun Sep Year
’26 1,156 1,172 1,175 — —
’25 1,110 1,128 1,144 1,150 4,533
’24 1,245 1,246 1,250 1,264 5,005
’23 1,186 1,223 1,236 1,243 4,888
’22 1,105 1,145 1,160 1,167 4,577
’21 1,086 1,049 1,066 1,087 4,289
’20 1,042 1,048 1,026 1,053 4,169
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Dec Mar Jun Sep Year
’26 220 102 197 — —
’25 106 172 241 230 749
’24 182 133 191 218 724
’23 83 294 173 272 823
’22 204 169 167 217 757
’21 416 120 190 200 926
’20 164 103 187 205 658
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Dec Mar Jun Sep Year
’26 188 80 172 — —
’25 78 156 212 199 645
’24 139 113 175 192 619
’23 50 259 144 272 724
’22 147 122 126 135 530
’21 366 70 140 139 715
’20 105 57 145 145 453
in millions of $ · fiscal quarters ending in the months shown

EPS

Dec Mar Jun Sep Year
’26 1.45 1.28 0.59 — —
’25 1.33 1.45 1.39 0.88 5.05
’24 1.26 1.01 1.21 0.76 4.25
’23 1.07 1.23 1.32 0.86 4.49
’22 1.07 1.28 1.04 1.05 4.44
’21 2.28 0.91 1.14 0.97 5.32
’20 0.85 0.94 0.90 1.01 3.71
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

2
1Buy 2 3Hold 4 5Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
50.06 56.10 55.89 52.60 44.05 67.40 72.63 78.38 74.41 74.32

Analyst estimates 2026–2028

Powerpack
Low Price
61.33 67.98 71.72 72.89 77.29 82.38 91.24 99.75 94.04 95.41
High Price
25,561 24,670 24,381 24,516 25,875 27,176 30,288 30,695 29,058 26,969
Employees
0 0 0 0 0 0 0 0 0 0
Revenue/Emp
3,718 3,867 3,975 4,087 4,169 4,289 4,577 4,888 5,005 4,533
Revenue
35.24% 35.16% 34.71% 35.08% 33.90% 34.46% 35.38% 35.35% 35.07% 37.98%
Gross Margin
485 513 422 568 583 814 648 636 591 693
EBT
13.04% 13.26% 10.61% 13.90% 13.99% 18.99% 14.17% 13.02% 11.81% 15.29%
EBT Margin
409 437 354 479 498 688 550 543 496 568
Net Income
212 215 211 206 199 209 225 196 196 196
Depreciation
25.15 26.70 28.12 29.94 31.44 33.72 37.81 41.54 44.17 41.56
Revenue/Sh
2.74 2.99 2.49 3.49 3.73 5.36 4.47 4.52 4.27 5.08
Earnings/Sh
4.19 4.39 3.94 4.81 4.96 7.28 6.25 6.99 6.39 6.87
Cash Flow/Sh
1.57 (0.92) (1.64) (0.94) (1.55) (1.65) (1.88) (0.84) (0.93) (0.95)
Capex/Sh
5.76 3.47 2.31 3.87 3.41 5.62 4.37 6.16 5.46 5.92
Free CF/Sh
23.36 24.68 24.70 25.96 27.64 28.58 29.41 30.32 30.88 31.82
Book Value/Sh
148 145 141 136 133 127 121 118 113 109
Shares
21.04 21.55 26.57 18.94 15.39 14.18 17.77 18.67 20.49 16.18
PE Ratio
2.30 2.42 2.33 2.21 1.83 2.25 2.10 2.02 1.98 1.97
PS Ratio
2.48 2.62 2.66 2.55 2.08 2.65 2.70 2.77 2.83 2.58
PB Ratio
2.06 2.22 2.23 2.12 1.82 2.23 2.10 2.04 2.04 2.09
EV/Sales
8.99 17.07 27.22 16.41 16.80 13.34 18.18 13.74 16.46 14.65
EV/FCF
620 636 557 656 658 926 757 823 724 749
Op' Cash Flow
232 (133) (231) (128) (206) (210) (227) (98) (105) (104)
Capex
852 503 326 528 453 715 530 724 619 645
FCF
734 876 426 468 858 764 750 558 300 233
Working Cap'
200 — — — 974 881 826 807 750 788
Total Debt
(896) (980) (519) (472) (10) (84) 9 65 235 463
Net Debt
3,454 3,574 3,492 3,542 3,665 3,635 3,560 3,567 3,499 3,471
Sh' Equity
7.68% 8.17% 6.62% 8.95% 8.50% 10.60% 8.40% 8.29% 7.55% 8.77%
ROA
11.81% 12.46% 9.00% 11.60% 10.17% 10.54% 11.64% 11.25% 10.52% 11.63%
ROIC
11.93% 12.33% 9.96% 13.54% 13.71% 18.67% 15.05% 14.92% 13.70% 15.90%
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Sep 2025 · latest quarter Jun 2026

Amdocs Limited peers in Software Infrastructure

Company Market cap P/E Compare
WEX WEX Inc. $6.3B 17.5× Compare
QLYS Qualys, Inc. $6.3B 29.7× Compare
BLSH Bullish $6.0B 0.0× Compare
CORZ Core Scientific, Inc. $5.9B 0.0× Compare
Company Market cap P/E Compare
PATH UiPath, Inc. $6.6B 18.6× Compare
VRNS Varonis Systems, Inc. $5.5B 0.0× Compare
DBX Dropbox, Inc. $7.1B 17.7× Compare
ZETA Zeta Global Holdings Corp. $7.4B 0.0× Compare

All 173 Software Infrastructure stocks →

Amdocs Limited (DOX) key facts

  • Amdocs Limited (DOX) is a Software Infrastructure company in the Technology sector, listed on Nasdaq.
  • Amdocs Limited’s revenue for fiscal 2025 (year ended September 2025) was $4.5 billion, down 9.43% from fiscal 2024.
  • As of September 25, 2026, DOX traded at $57.71, a market capitalization of $6.2 billion.
  • Amdocs Limited pays an annual dividend of $1.74 per share, a yield of 1.98%, with a payout ratio of 35.6%.
  • Return on equity was 15.9% and debt-to-equity 0.32.

Source: company filings (standardised) and stockrow calculations.

Amdocs Limited (DOX) Latest News

News by impact score

Fine-tune

24 Sep

3

Amdocs (DOX) is labeled a sell amid revenue declines, tepid expected growth, and shrinking returns on capital in a competitive environment. The piece notes customers delaying purchases, projects around 3.4% growth, and a 7.5x forward P/E at $58.36. It contrasts DOX with Dell (buy) and Kforce (sell), while acknowledging industry gains of 22.8% over six months but warning that demand in business services remains tied to the broader economy. Declining revenue, tepid forward growth, and shrinking returns amid competition could curb DOX's earnings trajectory.

22 Sep

3

Amdocs (DOX) trades at $59.50 and has fallen 8.6% over six months, lagging the S&P 500's 16.2% gain. Three risk factors are cited: long-term revenue growth has been weak (5-year CAGR of 1.8%), 12-month revenue growth is forecast at just 3.4% (below sector averages), and ROIC has declined by about 3 percentage points per year, signaling fading profitable growth opportunities. The stock's forward P/E is about 7.5x, suggesting cheap valuation but meaningful downside given fundamentals. A more attractive pick is described as the most dominant software business in the world, with additional promotion of momentum stocks via an AI platform. Three explicit red flags (sluggish long-term growth, slim near-term growth, and declining ROIC) imply meaningful downside despite valuation, though the piece favors an alternative stock and momentum plays.

4 Sep

3

Amdocs (DOX) stock rose 7% since last earnings report on positive investor reaction to financial results and outlook. Post-earnings share gains reflect moderate lift to near-term sentiment and valuation without major operational changes.

29 Aug

4

Amdocs secured an AI-driven deal with Telefonica Chile that targets managed services expansion and could reshape the company's operational trajectory. AI-driven Telefonica Chile contract marks a major strategic move capable of significantly shifting Amdocs managed services path and investor view.

13 Aug

4

Amdocs Limited pursues growth in telco AI by developing agentic platforms and advancing edge computing capabilities. Strategic push into AI platforms and edge computing targets major telco opportunities and could significantly alter Amdocs trajectory.

3 transcript

Amdocs Limited (DOX) released its Q3 2026 earnings call transcript covering financial results, operational updates, and forward outlook. Quarterly earnings transcripts deliver financial metrics that moderately shape near-term investor views and stock movement.

11 Aug

3

Amdocs Limited's Q2 results highlight Agentic Strategy and aOS Platform as primary drivers of customer engagement. Agentic Strategy and aOS Platform advances point to noticeable but not transformative effects on Amdocs competitive positioning and performance.

6 Aug

3

Amdocs Limited reported third-quarter earnings that met estimates, with managed services reaching record levels. Record managed services and in-line earnings indicate moderate positive effects on near-term revenue stability.

3 transcript

Amdocs Limited held its Q3 2026 earnings call covering quarterly financial results, operational updates and forward guidance. Quarterly earnings release and guidance directly inform near-term revenue, margins and investor expectations.

5 Aug

4

Amdocs Limited reported third quarter fiscal 2026 results including revenue, earnings per share, and forward guidance. Quarterly earnings data directly shapes investor views on valuation and near-term trajectory.

4

Liberty Latin America announces 10-year strategic engagement with Amdocs Limited. 10-year engagement secures major long-term revenue and bolsters Amdocs position in Latin America.

3 transcript

Amdocs Limited held its Q3 earnings call, presenting highlights on financial results, operations, and outlook. Routine quarterly earnings updates typically yield moderate short-term market effects without major strategic shifts.

3

Amdocs Limited (DOX) Q3 earnings key metrics are analyzed for insights into financial and operational performance. Q3 earnings metrics analysis can moderately shape Amdocs investor sentiment and near-term stock trajectory.

3

Cielo selects Amdocs to implement intelligent connectivity across its entire Brazilian payment terminal network. Contract expands Amdocs presence in Brazilian payments infrastructure.

3

Optimum implements Amdocs aOS Cognitive Core to power an AI-enhanced platform that transforms its customer billing experience. Optimum deployment validates Amdocs AI billing technology and supports modest revenue growth without shifting overall trajectory.

3

Lumen extends multi-cloud strategy via partnership with Amdocs to modernize enterprise service orchestration. Deal with Lumen supports Amdocs enterprise growth but remains one contract among broader operations.

3

PLDT Home selects Amdocs to modernize its core business platform, advancing cloud-ready transformation. PLDT Home contract win supports Amdocs revenue growth in telecom modernization.

3

Sunrise extends strategic collaboration with Amdocs to advance CRM evolution using aOS. Extended Sunrise partnership supports Amdocs revenue and aOS adoption in telecom without broad market shift.

3

Vivo selects Amdocs to advance OSS modernization with upgrade to Amdocs CES2X. Vivo contract for OSS upgrade adds moderate revenue and positions Amdocs in telecom modernization.

3

Amdocs (DOX) could be 31% undervalued following Q2 earnings focus. Q2 earnings valuation analysis indicates moderate potential to influence investor sentiment and stock trajectory.

13 Jul

3

Amdocs Limited secures a deal with Three Scandinavia alongside new analyst coverage that may shift investment outlook for the company. Scandinavia contract and fresh coverage point to moderate effects on Amdocs operations and investor views.

3

Amdocs (DOX) stock may trade below fair value following AI RAN news. AI RAN news creates competitive pressure that can shift Amdocs valuation and short-term market sentiment.

8 Jul

3

Amdocs (DOX) encounters significant difficulties advancing its AI initiatives, threatening operational efficiency and long-term market positioning. AI implementation struggles may slow product innovation and affect competitive standing without fundamentally reshaping company trajectory.

2 Jul

3

Amdocs (DOX) with 1Finity and Supermicro (SMCI) validated an AI-RAN blueprint on NVIDIA (NVDA) infrastructure. AI-RAN blueprint validation expands Amdocs telecom software positioning in emerging AI infrastructure.

24 Jun

3

Amdocs selected by Three Scandinavia to support customer engagement transformation across Nordic markets. Contract win adds revenue and Nordic footprint for Amdocs but remains incremental to overall operations.

23 Jun

4

Amdocs launches live multivendor AI-RAN solution and industry blueprint to advance aOS network workflows. Multivendor AI-RAN launch strengthens Amdocs position in telecom network automation and 5G infrastructure.

21 May

3

Microsoft and Amdocs deepen collaboration on Azure cloud services while Workday adopts Microsoft 365 Copilot. Expanded Azure partnership strengthens Amdocs cloud positioning and opens incremental revenue opportunities without altering core trajectory.

3

Amdocs Limited partners with Alphabet Inc. to expand the Gemini Enterprise Agent Marketplace, integrating Amdocs solutions into Google's AI enterprise offerings. Partnership integrates Amdocs into Alphabet's Gemini AI marketplace, offering moderate gains in product reach and positioning within enterprise software.

15 May

3

Amdocs reported mixed Q2 2026 results, with revenue slightly missing estimates but EPS beating, alongside positive traction updates for its aOS platform, suggesting cautious optimism for shareholders amid strategic AI advancements. Mixed quarterly earnings and product traction updates will moderately affect financial performance and competitive positioning without fundamentally altering long-term trajectory.

14 May

4

Amdocs Q2 earnings surpassed analyst estimates, with revenues rising year-over-year. Q2 earnings beat and year-over-year revenue growth demonstrate strong financial performance, likely boosting stock price and investor sentiment.

stockrow.com/DOX · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com